** Shares of Atomo Diagnostics AT1.AX fall 11.8% to A$0.019, their biggest intraday pct jump since mid-August
** The medical device firm hits highest level since March 14
** Co signs an exclusive licensing agreement with the Burnet Institute for their novel rapid Syphilis test
** Says license gives co exclusive rights to commercialise the test
(Reporting by John Biju in Bengaluru)
((John.Biju@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。